DrugDrug NameDrug Indication
DB00627NiacinFor the treatment of type IV and V hyperlipidemia. It is indicated as ajunctive therapy.
DB08949Inositol nicotinateIndicated as a dietary supplement for the source of niacin. Has been investigated for potential beneficial effects on serum lipids. In Europe, inositol hexanicotinate is indicated as a patented drug known as Hexopal, which is therapeutically indicated for the symptomatic relief of severe intermittent claudication and Raynaud’s phenomenon.
DB09055AcipimoxUsed in the treatment of hyperlipidemias (abnormally elevated levels of any or all lipids and/or lipoproteins in the blood).